Funding healthcare-associated infection research: A systematic analysis of UK research investments, 1997-2010

Journal of Hospital Infection

Volumn 87, Issue 2, 2014, Pages 84-91

  Head, M G ^a   Fitchett, J R ^b   Holmes, A H ^c   Atun, R ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Funding; Healthcare associated; Meticillin resistant Staphylococcus aureus; Nosocomial; Research

Indexed keywords

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; CLOSTRIDIUM DIFFICILE; FUNDING; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ACQUIRED PNEUMONIA; INTRAVENOUS CATHETER; INVESTMENT; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOROVIRUS; PRION; PRODUCT DEVELOPMENT; PSEUDOMONAS; PUBLIC HEALTH; ROTAVIRUS INFECTION; STREPTOCOCCUS INFECTION; SURGICAL INFECTION; UNITED KINGDOM; URINARY CATHETER; VIRUS HEPATITIS; CROSS INFECTION; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; PROCEDURES; STATISTICS AND NUMERICAL DATA;

BIOMEDICAL RESEARCH; CAPITAL FINANCING; CROSS INFECTION; GREAT BRITAIN; HEALTH POLICY; HUMANS; INFECTION CONTROL;

EID: 84901676936     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.03.008     Document Type: Article

References (28)

1. Wilson J., Guy R., Elgohari S., et al. Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009. J Hosp Infect 2011, 79:211-217.
2. Aldeyab M.A., Kearney M.P., Scott M.G., et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 2012, 67:2988-2996.
3. Smits W.K. Hype or hypervirulence: a reflection on problematic C. difficile strains. Virulence 2013, 4:592-596.
4. Evans B.A., Hamouda A., Amyes S.G.B. The rise of carbapenem-resistant Acinetobacter baumannii. Curr Pharm Des 2013, 19:223-238.
5. Danial J., Cepeda J.A., Cameron F., Cloy K., Wishart D., Templeton K.E. Epidemiology and costs associated with norovirus outbreaks in NHS Lothian, Scotland 2007-2009. J Hosp Infect 2011, 79:354-358.
6. Lanini S., Puro V., Lauria F., et al. Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med 2009, 7:15.
7. Wise J. Three babies die in pseudomonas outbreak at Belfast neonatal unit. BMJ 2012, 344:e592.
8. Plowman R. The socioeconomic burden of hospital acquired infection. Eurosurveillance 2000, 5:49-50.
9. Murray E., Holmes A. Addressing healthcare-associated infections and antimicrobial resistance from an organizational perspective: progress and challenges. J Antimicrob Chemother 2012, 67(Suppl. 1):i29-i36.
10. Zimlichman E., Henderson D., Tamir O., et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013, 173:2039-2046.
11. Durlach R., McIlvenny G., Newcombe R.G., et al. Prevalence survey of healthcare-associated infections in Argentina; comparison with England, Wales, Northern Ireland and South Africa. J Hosp Infect 2012, 80:217-223.
12. Toledo P.V.M., Arend L.N., Pilonetto M., Costa Oliveira J.C., Luhm K.R. Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: an urban perspective in South Brazil. J Hosp Infect 2012, 80:351-353.
13. Lambert M.-L., Suetens C., Savey A., et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011, 11:30-38.
14. Van Kleef E., Robotham J.V., Jit M., Deeny S.R., Edmunds W.J. Modelling the transmission of healthcare associated infections: a systematic review. BMC Infect Dis 2013, 13:294.
15. Allegranzi B., Bagheri Nejad S., Combescure C., et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011, 377:228-241.
16. Head M.G., Fitchett J.R., Cooke M.K., Wurie F.B., Hayward A.C., Atun R. UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis 2013, 13:55-64.
17. ResIn (Research Investments in Global Health). Available at: [accessed 01.04.14]. http://www.researchinvestments.org.
18. ResIn. Available at: [accessed 01.04.14]. http://researchinvestments.org/data/.
19. Head M.G., Fitchett J.R., Cooke M.K., et al. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother 2014, 69:548-554.
20. Davies S.C., Fowler T., Watson J., Livermore D.M., Walker D. Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. Lancet 2013, 381:1606-1609.
21. Stone S.P., Fuller C., Savage J., et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ 2012, 344:e3005.
22. Hughes G.J., Nickerson E., Enoch D.A., et al. Impact of cleaning and other interventions on the reduction of hospital-acquired Clostridium difficile infections in two hospitals in England assessed using a breakpoint model. J Hosp Infect 2013, 84:227-234.
23. Goldenberg S.D., Patel A., Tucker D., French G.L. Lack of enhanced effect of a chlorine dioxide-based cleaning regimen on environmental contamination with Clostridium difficile spores. J Hosp Infect 2012, 82:64-67.
24. Dancer S.J. Hospital cleaning in the 21st century. Eur J Clin Microbiol Infect Dis 2011, 30:1473-1481.
25. Gould D. Healthcare-associated respiratory tract infection. Nurs Stand 2013, 27:50-56.
26. Andrews N. Incidence of variant Creutzfeldt-Jakob disease diagnoses and deaths in the UK, January 1994-December 2011 2012, Public Health England, London.
27. Coker R.J., Atun R.A., McKee M. Health-care system frailties and public health control of communicable disease on the European Union's new eastern border. Lancet 2004, 363:1389-1392.
28. Murray C.J.L., Ezzati M., Flaxman A.D., et al. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet 2012, 380:2055-2058.